Systemic-to-Pulmonary Collateral Flow Correlates with Clinical Condition Late After the Fontan Procedure

Yoshihiko Kodama1,2, Yuichi Ishikawa3, Ayako Kuraoka3

  • 1Department of Pediatric Cardiology, Fukuoka Children's Hospital, 5-1-1 Kashiiteriha, Fukuoka, Japan. kodamayoshihiko@gmail.com.

Pediatric Cardiology
|September 11, 2020
PubMed

Insights

Systemic-to-pulmonary collateral flow (SPCF) in Fontan circulation, measured by cardiac magnetic resonance (CMR), correlates with long-term clinical outcomes. Higher SPCF is linked to poorer outcomes, emphasizing pulmonary vascular bed development.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Medical Imaging

Background:

  • The Fontan procedure creates a unique circulation with significant systemic-to-pulmonary collateral flow (SPCF).
  • Understanding the correlation between SPCF and long-term outcomes is crucial for patient management.
  • Cardiac magnetic resonance (CMR) is a key imaging modality for quantifying SPCF.

Purpose of the Study:

  • To investigate the relationship between the degree of systemic-to-pulmonary collateral flow (SPCF) and long-term clinical outcomes in patients with Fontan circulation.
  • To identify factors associated with SPCF in this patient population.

Main Methods:

  • Retrospective study of 321 patients who underwent Fontan procedure and CMR.
  • SPCF calculated using CMR as pulmonary blood flow minus systemic blood flow.
  • %SPCF defined as (SPCF / pulmonary blood flow) * 100.

Main Results:

  • Mean %SPCF was 13.0% ± 11.0%.
  • %SPCF correlated inversely with time since Fontan procedure, and positively with older age at Fontan, previous total anomalous pulmonary vein drainage, and lower pre-Fontan Nakata index.
  • %SPCF was significantly associated with increased ventricular volumes, elevated central venous pressure, higher brain natriuretic peptide levels, hemoptysis, and poorer NYHA functional class.

Conclusions:

  • SPCF is a significant indicator of clinical condition after the Fontan procedure.
  • The development of SPCF may stem from inadequate pulmonary vascular bed development.
  • Emphasizing pulmonary vascular bed growth is vital for improving long-term outcomes in Fontan patients.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
211
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
335
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
282
Overview of Systemic and Pulmonary Circulation01:15

Overview of Systemic and Pulmonary Circulation

The systemic and pulmonary circuits are crucial components of the circulatory system, working together to transport blood between the heart, lungs, and the rest of the body. The process begins with pulmonary circulation, where deoxygenated blood is pumped from the right ventricle to the lungs via the pulmonary trunk and arteries. Upon reaching the lungs, the blood becomes oxygenated and returns to the heart, specifically to the left atrium, via the pulmonary veins.
The oxygenated blood is sent...
9.5K
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
186
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
120